| Phase 1 | 1 | |
| Phase 2 | 2 |
| NCT ID | Title | Condition | Status | Updated |
|---|---|---|---|---|
| Phase 2 | ||||
| NCT05529316 | A Study of Botensilimab (AGEN1181) for the Treatment of Advanced Melanoma | Advanced Melanoma | Active, Not Recruiting | 2026-01-16 |
| NCT05608044 | A Study of Botensilimab and Balstilimab for the Treatment of Colorectal Cancer | Metastatic Colorectal Cancer | Active, Not Recruiting | 2025-09-04 |
| Phase 1 | ||||
| NCT03860272 | Fc-Engineered Anti-CTLA-4 Monoclonal Antibody in Advanced Cancer | Advanced Cancer | Active, Not Recruiting | 2026-03-30 |
Colorectal Cancer (2) · Endometrial Cancer (1) · Lung Cancer (1) · Melanoma (1) · Non-Small Cell Lung Cancer (NSCLC) (1) · Ovarian Cancer (1) · Prostate Cancer (1) · Sarcoma (1)